Aide et accompagnement au sevrage tabagique : partie intégrante du traitement du cancer ORL.

ENT cancer; Smoking; Humans; Head and Neck Neoplasms/therapy; Head and Neck Neoplasms/psychology; Quality of Life; Smoking Cessation/methods; Smoking - ENT cancer; Head and Neck Neoplasms; Smoking Cessation; Medicine (all)

Abstract :

[en] Inform, prevent, educate and encourage are the key words must be the keywords of all stakeholders who take care of a patient with ENT cancer in order to potentiate the effectiveness of the different treatments but also to improve the quality of life of patients.
[fr] Les cancers ORL sont favorisés par le tabagisme. Beaucoup de nos patients ne connaissent pas les conséquences qui découlent de leur assuétude. Informer, prévenir, éduquer et encourager doivent être les mots clé de tous les intervenants qui prennent en charge un patient atteint d’un cancer ORL afin de potentialiser l’efficacité des différents traitements mais aussi d’améliorer la qualité de vie des patients.

Disciplines :

Oncology

Author, co-author :

PRINCEN, Fabienne ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de radiothérapie

Goffinet, Maxime ; Centre Hospitalier Universitaire de Liège - CHU > > Service d'ORL, d'audiophonologie et de chir. cervico-faciale

Poncin, Aurélie ; Université de Liège - ULiège > Département des sciences cliniques

PIRET, Pascal ; Centre Hospitalier Universitaire de Liège - CHU > > Service médical de radiothérapie

Language :

French

Title :

Aide et accompagnement au sevrage tabagique : partie intégrante du traitement du cancer ORL.

Alternative titles :

[en] Help and support for smoking cessation : an integral part of the treatment of ENT cancer.

Publication date :

May 2024

Journal title :

Revue Médicale de Liège

ISSN :

0370-629X

eISSN :

2566-1566

Publisher :

Revue Medicale de Liege, Belgium

Volume :

Issue :

Pages :

113 - 116

Peer reviewed :

Editorial Reviewed verified by ORBi

Available on ORBi :

since 06 February 2025

Statistics

Number of views

15 (1 by ULiège)

Number of downloads

8 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenAlex citations

Bibliography

Tao L, Wang R, Gao Y, Yuan JM. Impact of post-diagnosis smoking on long-term survival of cancer patients: the Shangai cohort study. Cancer Epidemiol Biomarkers Prev 2013;22:2404-11.
Burke L, Miller LA, Saad A, Abraham J. Smoking behaviors among cancer survivors: an observational clinical study. J Oncol Pract 2009;5:6-9.
Gritz ER, Fingeret MC, Vidrine DJ, et al. Successes and failures of the teachable moment: smoking cessation in cancer patients. Cancer 2006;106:17-27.
Dautzenberg B. Sevrage tabagique, mise au point sur la prise en charge actuelle et ses résultats. Bull Cancer 2012;99:1007-15.
NCCN Guidelines Version 1.2015 Smoking cessation. Smoking-associated risks for cancer (SC-A1 of 2). Available from: https://www.nccn.org/home. Dernière consultation 14/09/2023.
Radoï L, Paget-Bailly S, Cyr D, et al. Tobacco smoking, alcohol drinking and risk of oral cavity cancer by subsite: results of a French population-based-case-control study, the ICARE study. Eur J Cancer Prev 2013;22:268.
Chellappan S. Smoking cessation after cancer diagnosis and enhanced therapy response: mechanisms and significance. Curr Oncol 2022;29:9956-69.
IARC Working Group. Tobacco smoking. IARC Monographs on the evaluation of carcinogenic risks to humans, 2012.
Agostini P, Cieslik H, Rathinam S, et al. Postoperative pulmonary complications following thoracic surgery: are there any modifiable risk factors? Thorax 2010;65:815-8.
Centers for Disease Control and Prevention (CDC). Cigarette smoking among adults and trends in smoking cessation - United States, 2008. MMWR Morb Mortal Wkly Rep 2009;58:1227-32.
Crippen MM, Patel N, Filimonov A, et al. Association of smoking tobacco with complications in head and neck microvascular reconstructive surgery. JAMA Facial Plast Surg 2019;21:20-6.
Silverstein P. Smoking and wound healing. Am J Med 1992;93:22S-4S.
Jorgensen LN, Kallehave F, Christensen E, et al. Less collagen production in smokers. Surgery 1998;123:450-5.
Kuri M, Nakagawa M, Tanaka H, et al. Determination of the duration of preoperative smoking to improve wound healing after head and neck surgery. Anesthesiology 2005;102:892-6.
Wong J, Lam DP, Abrishami A, et al. Short-term preoperative smoking cessation and postoperative complications: a systematic review and meta-analysis. Can J Anesth 2012;59:268-79.
Garip M, Van Dessel J, Grosjean L, et al. The impact of smoking on surgical complications after head and neck reconstructive surgery with a free vascularised tissue flap: a systematic review and meta-analysis. Br J Oral Maxillofac Surg 2021;59:e79-98.
Hamoir M, Holvoet E, Ambroise J, et al. Salvage surgery in recurrent head and neck squamous cell carcinoma: oncologic outcome and predictors of disease free survival. Oral Oncol 2017;67:1-9.
O’Malley M, KIng A, Conte M, et al. Effects of cigarette smoking on metabolism and effectiveness of systemic therapy for lung cancer. J Thorac Oncol 2014;9:917-26.
Heeschen C, Weis M, Aicher A, et al. A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J Clin Invest 2002;110:527-36.
Heeschen C, Jang JJ, Weis M, et al. Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nat Med 2001;7:833-9.
Dasgupta P, Kinkade R, Joshi B, et al. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proc Natl Acad Sci USA 2006;103:6332-7.
Xu J, Huang H, Pan C, et al. Nicotine inhibits apoptosis induced by cisplatin in human oral cancer cells. Int J Oral Maxillofac Surg 2007;36:739-44.
Mai H, May WS, Gao F, et al. A functional role for nicotine in Bcl2 phosphorylation and suppression of apoptosis. J Biol Chem 2003;278:1886-91.
Peppone LJ, Mustian KM, Morrow GR, et al. The effect of cigarette smoking on cancer treatment–related side effects. Oncologist 2011;16:1784-92.
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.
Calles A, Liao X, Sholl LM, et al. Expression of PD-1 and its ligands, PD-L1 and PD-L2, in smokers and never smokers with KRAS-Mutant lung cancer. J Thorac Oncol 2015;10:1726-35.
Wang GZ, Zhang L, Zhao XC, et al. The aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy. Nat Commun 2019;10:1125.
Xiao F, Liu Y, Zhang Z, et al. Tobacco extracts promote PD-L1 expression and enhance malignant biological differences via mTOR in gefitinib-resistant cell lines. Thorac Cancer 2020;11:2237-51.
Hoff CM. Importance of hemoglobin concentration and its modification for the outcome of head and neck cancer patients treated with radiotherapy. Acta Oncol 2012;4:419-32.
Zevallos JP, Mallen MJ, Lam CY, et al. Complications of radiotherapy in laryngopharyngeal cancer effects of a prospective smoking cessation program. Cancer 2009;115:4636-44.
Sathasivam HP, Davies GR, Boyd MN. Predictive factors for osteoradionecrosis of the jaws: a retrospective study. Head Neck 2018;40:46-54.